Burden of Cardiopulmonary Diseases and Lung Cancer Due to PM2.5 Exposure in 11 Polish Agglomerations in 2006-2015

Artur Jerzy Badyda , P Dąbrowiecki , A Chciałowski


75% of Europeans live in cities. The European Environment Agency estimates that exposure to concentrations oi PM“; and PM2_5 above the limit values in cities of the EU conoems 8-21% of the population land 50-91%. when taking into account the WHO guideli nes}. Materials and methods: Data trom the Polish State Environmental Monitoring on concentrations of PM25 and PM“; in 11 urban areas {with over 250.000 inhabitants) trom a 10 year period (2006-2015) and data on mortality due to lung cancer, cardiopulmonary diseases, and on total non-violent mortality has been used. Using the exposure-response functions detined by Pope et al., JAMA 2002;287:1132-1141 and Krewski et a|., HEI 2009 (research report) the environmental burden of diseases attributable to exposure to ambient PM pollution has been assessed. Results: In the analyzed period the annual mean concentration of PM25 exceeded the EU limit value in 9 (out of 1 1) cities in at least one air quality monitoring station. The WHO recommended concentration of PM“ was exceeded in all ot the analyzed cities {also in all monitoring stations) during the whole period. Due to the relatively high concentrations ot PM in Polish cities {one of the highest in the EU) population attributable traction (PAF) is also relatively high. Average PAF varied depending on the year and city from 0.10 to 0.53 tor mortality due to lung cancer, from 0.15 to 0.68 for ischemic heart disease (IHD) and trom 0.0? to 0.39 lor all cardiopulmonary diseases. The number of yearly mortality that could be attributed to PM25 varied trom 24 to 438 tor lung cancer and trom 1 16 to 2093 for cardiopulmonary diseases {including 51 to 1186 cases of IHD). Conclusion: A signiticant partot Polish cities population is exposed to concentrations exceeding the allowable PM level. This results in persistently high and even increasing rates of people dying trom lung cancer and cardiopulmonary diseases due to the poor airquality.
Publication typeOriginal work published as abstract
Author Artur Jerzy Badyda (FEE / DISEQR)
Artur Jerzy Badyda,,
- Department of Informationa Science and Environment Quality Research
, P Dąbrowiecki
P Dąbrowiecki,,
, A Chciałowski
A Chciałowski,,
Journal seriesAmerican Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, (A 50 pkt)
Issue year2018
Publication size in sheets0.3
ConferenceAmerican Thoracic Society 2018 International Conference (ATS 2018), 18-05-2018 - 23-05-2018, San Diego, Stany Zjednoczone
Keywords in Polishchoroby płuc, nowotwór płuc, PM2,5
ASJC Classification2706 Critical Care and Intensive Care Medicine; 2740 Pulmonary and Respiratory Medicine
URL https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A2817
Languageen angielski
Score (nominal)0
Score sourceconferenceIndex
Publication indicators WoS Citations = 0; Scopus SNIP (Source Normalised Impact per Paper): 2018 = 3.201; WoS Impact Factor: 2018 = 16.494 (2) - 2018=15.196 (5)
Citation count*
Share Share

Get link to the record

* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Are you sure?